Navigation Links
Life Technologies Launches New Distribution Center in India

CARLSBAD, Calif. and BANGALORE, India, July 10, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today that it has launched a regional distribution hub in India to address strong customer demand in the South Asia region.

The new India Distribution Center (IDC), located in Bangalore, will boost the availability, timely delivery and quality of Life Technologies' products to its thousands of customers in the area.

"The scientific community in India is growing at a rapid rate," said Devashish Ohri, Managing Director of Life Technologies South Asia. "By locating the India Distribution Center in Bangalore, we can bring our innovative technologies more efficiently to our customers and partners in the region and help advance their science."

"South Asia is one of the fastest growing regions in the world," said Mark Smedley, President of Asia Pacific and Japan for Life Technologies. "Opening the India Distribution Center here is a clear demonstration of Life Technologies' commitment to the scientific community to greatly enhance the timeliness, accuracy and reliability of our product distribution to our Indian customers."

The India Distribution Center, which spans a built-up area of 25,000 square feet, adopts a hub-and-spoke model, with Bangalore as the regional hub for Life Technologies' product distribution throughout India. Since the IDC's inception, Life Technologies' volume of items shipped per day in the region has increased fourfold, with dramatically improved order fulfillment time that is up to 50 percent faster in most cases.

Life Technologies operates as Invitrogen Bioservices India Pvt. Ltd. in India and commenced operations in the year 2005 from Bangalore.  The company recently acquired a part of Labindia, a long time distributor for its Applied Biosystems branded instrument products to become a full service business that offers end-to-end solutions in areas such as research, diagnostics and forensics.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition.  Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better.  Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics.  The company manufactures both molecular diagnostic and research use only products.  Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, Gibco, Ambion, Molecular Probes and Taqman products.  Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses.  For more information on how we are making a difference, please visit our website:  Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.


Life Technologies Contact:

Vivian Lv
PR & Communications, APAC
+86 10 8446 1901

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Biobanking: Technologies and Global Markets
2. Stem Cell Technologies: World Market Outlook 2011-2021
3. Wound Management Technologies Webcasting Live from OneMedForum NY Biotech Conference on Thursday, June 23 at 10 am EDT
4. CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification
5. Genetic Technologies Launches BREVAGen™ Breast Cancer Risk Test in US
6. Statement by Ronald L. Stotish, Ph.D., President and CEO of AquaBounty Technologies
7. Life Technologies Launches Highly Efficient Stem Cell Reprogramming Technology
8. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
9. Merriman Capital Announces Sponsorship of Circadian Technologies on OTCQX
10. Fox Chase Cancer Center Signs Agreement with Life Technologies Corporation
11. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
Post Your Comments:
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... SHPG ) announced today that Jeff ... 27 th Annual Healthcare Conference in New York ... a.m. EST (1:30 p.m. GMT). --> SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
(Date:11/24/2015)... ... 2015 , ... In harsh industrial processes, the safety of ... can represent a weak spot where leaking process media is a possible hazard. ... , which are designed to tolerate extreme process conditions. They combine rugged design ...
(Date:11/24/2015)... Nov. 24, 2015 HemoShear Therapeutics, LLC, ... drugs for metabolic disorders, announced today the appointment ... Board of Directors (BOD). Mr. Watkins is the ... Genome Sciences (HGS), and also served as the ... Jim Powers , Chairman and CEO of HemoShear ...
Breaking Biology Technology:
(Date:11/18/2015)...  As new scientific discoveries deepen our understanding of ... providers face challenges in better using that knowledge to ... as more children continue to survive pediatric cancer, that ... age. John M. Maris, M.D ., a ... (CHOP) . --> John M. Maris, ...
(Date:11/17/2015)... , November 17, 2015 Paris ... 2015.   --> Paris from 17 ... DERMALOG, the biometrics innovation leader, has invented the first ... fingerprints on the same scanning surface. Until now two different ... Now one scanner can capture both on the same ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
Breaking Biology News(10 mins):